Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Colorcon
Mallinckrodt
Baxter
Merck

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Litigation Details for In re: Rembrandt Technologies LP Patent Litigation (D. Del. 2007)

See Plans and Pricing

« Back to Dashboard

In re: Rembrandt Technologies LP Patent Litigation (D. Del. 2007)

Docket   Start Trial Date Filed 2007-06-21
Court District Court, D. Delaware Date Terminated 2011-09-07
Cause 28:1338 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Defendant Referred To
Parties ABC INC.; ADELPHIA COMMUNICATIONS CORP.; ADELPHIA COMMUNICATIONS CORPORATION; CENTURY-TCI CALIFORNIA, LP; CENTURY-TCI CALIFORNIA COMMUNICATIONS, LP; CENTURY-TCI ; ADELPHIA CONSOLIDATION, LLC; AMBIT MICROSYSTEMS INC.; AMBIT MICROSYSTEMS, INC.; ARRIS GROUP, INC.; CABLEVISION SYSTEMS CORPORATION; CBS CORPORATION; CENTURY-TCI CALIFORNIA COMMUNICATIONS LP; CENTURY-TCI DISTRIBUTION CO. LLC; CENTURY-TCI HOLDINGS LLC; CHARTER COMMUNICATIONS INC.; CHARTER COMMUNICATIONS OPERATING LLC; CISCO SYSTEMS, INC.; CLERK JEFFERY N. LUTHI; COMCAST CABLE COMMUNICATIONS LLC; COMCAST CORP.; COMCAST OF FLORIDA/PENNSYLVANIA, L.P.; COMCAST OF PENNSYLVANIA II, L.P.; COMCAST OF PLANO LP; COX COMMUNICATIONS, INC.; COX ENTERPRISES, INC.; COXCOM INC.; CSC HOLDINGS INC.; FISH & RICHARDSON PC; FOX BROADCASTING COMPANY; FOX ENTERTAINMENT GROUP INC.; MOTOROLA, INC.; NBC UNIVERSAL INC.; NETGEAR, INC.; PARNASSOS COMMUNICATIONS LP; PARNASSOS DISTRIBUTION CO. I LLC; PARNASSOS DISTRIBUTION II LLC; PARNASSOS HOLDINGS LLC; PARNASSOS LP; REMBRANDT TECHNOLOGIES LP; REMBRANDT TECHNOLOGIES LP PATENT LITIGATION; REMBRANDT TECHNOLOGIES, LLC D/B/A REMSTREAM; ROBERT W. FAULKNER; SCIENTIFIC-ATLANTA, INC.; SHARP CORP.; SHARP ELECTRONICS CORP.; THOMSON, INC.; TIME WARNER CABLE INC.; TIME WARNER CABLE LLC; TIME WARNER ENTERTAINMENT ADVANCE/NEWHOUSE PARTNERSHIP; TIME WARNER ENTERTAINMENT COMPANY L P; TIME WARNER NEW YORK CABLE LLC; WESTERN NY CABLEVISION LP
Patents 10,046,058; 10,047,033; 9,040,039; 9,056,057
Attorneys Aaron M. Panner; Albert J. Carroll; Albert J. Marcellino; Alfredo Silva; Allen Franklin Gardner; Anthony J. Magee; Benjamin Hershkowitz; Bradford P. Lyerla; Bradley Wayne Caldwell; Brian L. Ferrall; Brian Siritzky; Brooke A.M. Taylor; Carl N. Kunz , III; Charles Juister; Collins J. Seitz , Jr.; Daniel G. Bird; Daniel Reisner; Daralyn J. Durie; David A. Segal; David Ellis Moore; David J. Wolfsohn; David L. Schwarz; David S. Benyacar; David Sochia; Diane DeVasto; Douglas A. Cawley; Edgar G. Sargent; Edward R. Reines; Eric MacMichael; Erich M. Falke; Evan T. Leo; Francis DiGiovanni; Frederick L. Cottrell , III; Gabriel M. Ramsey; George Pazuniak; Gerald Levy; Harry Lee Gillam , Jr.; J.C. Rozendaal; Jack B. Blumenfeld; James D. Heisman; James Michael Lennon; James Walter Parrett , Jr.; Jamie Shouse; Jamie W. McGloin-King; Jason Carden Jowers; Jason Cassady; Jason James Rawnsley; Jason M. Wilcox; Jeffery N. Luthi; Jeffrey A. Carter; Jeffrey Thomas Castellano; Jennifer Haltom Doan; Jeremy S. Pitcock; John C. O'Quinn; John C. Rozendaal; John Christopher Rozendaal; John F. Garvish , II.; John F. Sweeney; John R. Labbe; John W. Shaw; Jonathan B Tropp; Joseph S. Grinstein; Josh A. Krevitt; Karen Jacobs; Karen Jacobs Louden; Kelly E. Farnan; Kevin D. Hogg; Kevin M. Baird; Kristen Healey Cramer; Leo L. Lam; Mark C. Hansen; Mary Matterer; Matthew M. Werdegar; Matthew R. Berry; Matthias Andreas Kamber; Max Lalon Tribble Jr.; Meghan Anne Adams; Michael A. Rogoff; Michael Edwin Jones; Michael J. Bonella; Mitchell G. Stockwell; Monica Bhattacharyya; Otis W. Carroll , Jr.; P. Clarkson Collins , Jr.; Paul B. Milcetic; Peter J. Toren; R. Scott Griffin; R. Scott Roe; Rebecca A. Beynon; Richard D. Kirk; Richard H. Brown; Richard H. Stern; Richard K. Herrmann; Richard L. Horwitz; Robert M Parker; Robert W. Faulkner; Rodger Dallery Smith , II; Samuel Franklin Baxter; Sarah J. Kalemeris; Stefan R. Stoyanov; Stephen B. Brauerman; Steven D. Chin; Steven J. Balick; Steven K. Taylor; T. Gordon White; Thomas G. Fasone , III.; Tibor L. Nagy , Jr.; Tonya R. Deem; Vineet Bhatia; William S. Feiler; William W. Oxley
Firms Bayard, P.A.; Clerk, MDL Judicial Panel; Day Pitney LLP; Deep Ellum Search; Devlin Law Firm LLC; Drinker Biddle & Reath LLP; Gillam and Smith LLP; Ireland Carroll & Kelley; Kasowitz Benson Torres & Friedman LLP; Kaye Scholer LLP; Kaye Scholer New York; Keker & Van Nest LLP; Keker and Van Nest; Marshall, Gerstein & Borun LLP; McKool Smith Marshall; Morris, Nichols, Arsht & Tunnell; Napoli Shkolnik, LLC; O'Kelly Ernst & Bielli, LLC; O'Kelly Ernst & Joyce, LLC; Parker Bunt & Ainsworth PC; Potter Minton; Prickett, Jones & Elliott, P.A.; Richards, Layton & Finger, PA; Robert W. Faulkner; Ross Aronstam & Moritz LLP; Seitz Ross Aronstam & Moritz LLP; Shaw Keller LLP; Susman Godfrey L.L.P.; Susman Godfrey LLP; Susman Godfrey, LLP; Undelverable Email 11/15/10; Womble Bond Dickinson (US) LLP
Link to Docket External link to docket
Small Molecule Drugs cited in In re: Rembrandt Technologies LP Patent Litigation
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in In re: Rembrandt Technologies LP Patent Litigation

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for In re: Rembrandt Technologies LP Patent Litigation (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2008-11-03 434 Transcript at the language of 10:47:33 9 what they actually said to the Patent Office, they were 10…about the '858 patent, which Your Honor will recall 09:09:18 20 is a patent to the network …means something to the patent, how it is being used in the 09:11:38 15 patent, and they have broken… look at how the patent uses it, that is 09:13:21 20 exactly how the patent uses it. You… The patent says -- and for the rest of the 09:40:38 21 patent we are going to External link to document
2008-11-03 435 Transcript 366 09:40:39 1 that has helped me is when you have…SWEENEY: The patent that is at issue today 09:39:43 12 is the '627 patent. It is entitled…Betts, the '625 patent, but it was incorporated in this 09:56:09 2 patent as well. And…like patent figures. But they 10:48:21 18 weren't actually from the patent. …thing that the patent says in introducing the 10:48:54 3 reader to the patent is, we are going External link to document
2008-11-03 436 Transcript where these patents came from, because Rembrandt 10:46:58 19 purchased the patents from a company…and file the patent on it. And that patent is the '858 10:50:48 17 patent, and it'…10:55:12 22 patent cases and I have been in a lot of multi-patent patent 10:55:16 23 …throughout the patent. 14:46:36 3 This patent is related to the earlier patent we 14…around the Sridhar patent, they tell the 14:47:26 18 Patent Office, our patent does the steps External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Mallinckrodt
Baxter
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.